Media Centre
News

Partners Talya Solomon and Iris Achmon’s newest article

Talya Solomon Iris Achmon

16 January 2023

Last week, the Competition Commissioner imposed an administrative fine on MBI Pharma Ltd., drugs importer for excessive pricing of a drug intended for the treatment of a rare metabolic condition known as Cerebrotendinous Xanthomatosis (CTX).

The company was fined NIS 8 million, and two senior executives were fined NIS 614,000 each. This is the first time that the Competition Commissioner in Israel has actually taken steps against monopoly excessive prices.

Read more here >>

Have a question on this topic? We are here to help

Every case is unique. Let's talk about yours.

Contact Us Now

More News, Insights & Events

The Israel Competition Authority Publishes Stringent New Draft Merger Guidelines for Public Comments Herzog Contributes Israeli Chapter to GCR Cases & Precedents 2026 Herzog Authors Israel Merger Control Chapter for Legal 500 Guide
JOIN OUR
Newsletter

    © 2020, All rights reserved, Herzog Law
    Site by Gootte

    The information contained in this web site is provided for informational purposes only and should not be construed as legal advice on any subject matter and should not be relied upon as such. Herzog accepts no responsibility for any consequences whatsoever arising from use of the information contained in this web site. The accessing of information contained in this web site shall under no circumstances be considered as creating an attorney-client relationship between Herzog and any party accessing this web site. Contacting through email any lawyer named in this web site or sending information without prior agreement of Herzog shall not be construed as automatically creating an attorney-client relationship between Herzog and the party sending an email or information. The material contained in this web site has been created by and remains the property of Herzog. No reproduction, transmission, publication or any other form of dissemination shall be permitted unless the prior written consent of Herzog has been obtained. This web site may contain links to other web sites operated by third parties. Herzog does not sponsor, approve or endorse the content of any such web site and is not responsible for the materials appearing in such sites.